Anversa cardiac stem cell lab earns 13 retractions

Two months after Harvard and the Brigham and Women’s Hospital said they were requesting the retraction of more than 30 papers from a former cardiac stem cell lab there, two American Heart Association journals have retracted more than a dozen papers from the lab. Yesterday, Circulation retracted three papers, and Circulation Research retracted 10. All 13 were … Continue reading Anversa cardiac stem cell lab earns 13 retractions

Journals stamp expressions of concern on 15 papers from Anversa’s cardiac stem cell lab

More than four and a half years after questions were first raised about work in a cardiac stem cell lab at Harvard and the Brigham and Women’s Hospital, a year and a half after the Brigham and Partners Healthcare paid $10 million to settle allegations of fraud in the lab’s data, a month after Harvard … Continue reading Journals stamp expressions of concern on 15 papers from Anversa’s cardiac stem cell lab

Bad image prompts correction of Harvard-Brigham stem cell paper by Anversa

A group of Harvard stem cell researchers who already have one retraction and an expression of concern now have a correction. This one’s in Circulation Research, and it involves an image that previously had been flagged as suspicious in our comments. The group is led by Piero Anversa, who as we reported last year is … Continue reading Bad image prompts correction of Harvard-Brigham stem cell paper by Anversa

The Year In Retractions, 2018: What 18,000+ retractions (and counting) told us

Another year in the books — or journals — already? 2018 was another  productive year for Retraction Watch. Topping our own leaderboard of achievements was the launch of our database of retractions, along with an analysis published in Science. With more than 18,000 entries, the repository is the largest of its kind. We are grateful … Continue reading The Year In Retractions, 2018: What 18,000+ retractions (and counting) told us

Weekend reads: Meet journals’ research integrity czars; Duke set to settle big grant fraud case; what a cannabis stock’s collapse can teach investors

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured some big numbers: 26 retractions for an engineer in Italy, … Continue reading Weekend reads: Meet journals’ research integrity czars; Duke set to settle big grant fraud case; what a cannabis stock’s collapse can teach investors

Weekend reads: A whistleblower speaks; a new most-cited retracted paper; criminalizing scientific fraud?

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a call for more than 30 retractions by former Harvard … Continue reading Weekend reads: A whistleblower speaks; a new most-cited retracted paper; criminalizing scientific fraud?

Harvard and the Brigham recommend 31 retractions for cardiac stem cell work

Retraction Watch readers may be familiar with the name Piero Anversa. Until several years ago, Anversa, a scientist at Harvard Medical School and the Brigham and Women’s Hospital, was a powerful figure in cardiac stem cell research. “For ten years, he ran everything,” says Jeffery Molkentin, a researcher at Cincinnati Children’s whose lab was among the … Continue reading Harvard and the Brigham recommend 31 retractions for cardiac stem cell work

Stem cell researchers investigated for misconduct recommended for roles at Italy’s NIH

Two stem cell scientists who left Harvard University in the aftermath of a messy misconduct investigation may have found new roles in Italy’s National Institute of Health. According to a document on the institute’s website, which we had translated, Piero Anversa and Annarosa Leri have been approved to start work at the Istituto Superiore di Sanità (ISS) … Continue reading Stem cell researchers investigated for misconduct recommended for roles at Italy’s NIH

Lawyers call libel suit against journal and critic “lawless” but “well written”

A $10 million defamation suit filed by a Stanford University professor against a critic and a journal may be an assault on free speech, according to one lawyer, but at least it’s “well written.” Kenneth White, a lawyer at Southern California firm Brown White & Osborn who frequently blogs about legal issues related to free … Continue reading Lawyers call libel suit against journal and critic “lawless” but “well written”

Harvard teaching hospital to pay $10 million to settle research misconduct allegations

Brigham and Women’s Hospital and its parent healthcare network have agreed to pay $10 million to the U.S. government to resolve allegations it fraudulently obtained federal funding. The case, which involves three former Harvard stem cell researchers, dates back several years. In 2014, Circulation retracted a paper by Piero Anversa, Annarosa Leri, and Jan Kajstura, … Continue reading Harvard teaching hospital to pay $10 million to settle research misconduct allegations